Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.173
-0.037 (-0.88%)
May 20, 2025, 1:03 PM - Market open
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $232.60 million as of May 20, 2025. Its market cap has decreased by -10.56% in one year.
Market Cap
232.60M
Enterprise Value
48.94M
1-Year Change
-10.56%
Ranking
Category
Stock Price
$4.17
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $232.60M, a decrease of -58.86%. That is a compound annual growth rate of -17.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 234.67M | -10.57% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | 721.42M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |